Trials / Completed
CompletedNCT04121871
Molecular Characterization of Candida Auris
Formulation Development and In-Vitro Studies of Efficacy of Botanical Extracts Against Candida Auris
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 384 (actual)
- Sponsor
- Islamia University of Bahawalpur · Academic / Other
- Sex
- All
- Age
- 100 Years
- Healthy volunteers
- Not accepted
Summary
Candida auris is emerging fungal opportunistic pathogen in developing countries. Much studies has been conducted on Candida albicans. there was a dire need to investigate this alarming threat. Our hypothesis is that by recording the patients diagnosed with oropharygneal candidiasis and collecting clinical swab samples from these patients will be fruitful if microbiological isolation, identification and molecular characterization will be done. So this is the first study on C. auris in south punjab, Pakistan. Aim of this study is to collect epidemiological data of C. auris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Not required |
Timeline
- Start date
- 2019-11-15
- Primary completion
- 2020-02-29
- Completion
- 2020-02-29
- First posted
- 2019-10-10
- Last updated
- 2020-10-27
Locations
2 sites across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT04121871. Inclusion in this directory is not an endorsement.